![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Maquet Joins Forces With Biotronik to Distribute Endovascular Devices in the U.S.
Maquet Joins Forces With Biotronik to Distribute Endovascular Devices in the U.S.
February 4, 2016
Maquet Medical Systems has entered into a partnership to distribute Biotronik’s peripheral vascular devices in the U.S.
Under the terms of the agreement, Maquet will distribute a range of Biotronik products used to treat peripheral artery disease, including the Astron iliac self-expanding stent, the Passeo percutaneous transluminal angioplasty balloon family and the Fortress family of reinforced sheaths.
Maquet will begin distributing Berlin, Germany-based Biotronik’s products during the first quarter of this year. — Jonathon Shacat
Upcoming Events
-
21Oct